Global and segmental myocardial strain in sarcoidosis: Associations with cardiac involvement and clinical impairment


Karaca Özer P., Yavuz M. L., Altan G., Gövdeli E. A., Dik S. A., Işık E. G., ...Daha Fazla

Respiratory Medicine, 2026 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Basım Tarihi: 2026
  • Doi Numarası: 10.1016/j.rmed.2026.109254
  • Dergi Adı: Respiratory Medicine
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE, Health Research Premium Collection (ProQuest)
  • Anahtar Kelimeler: Cardiac sarcoidosis, Functional capacity, Global longitudinal strain, NT-proBNP, Segmental strain, Speckle-tracking echocardiography
  • İstanbul Üniversitesi Adresli: Evet

Özet

Background: Cardiac involvement is a major determinant of morbidity and mortality in sarcoidosis and may remain clinically silent despite normal conventional cardiac evaluation. Advanced imaging modalities, particularly speckle-tracking echocardiography (STE), may detect subclinical myocardial dysfunction before overt clinical manifestations. This study aimed to evaluate global and segmental myocardial strain patterns in patients with pulmonary sarcoidosis and to investigate their associations with cardiac involvement, NT-proBNP levels, and functional capacity. Methods: This observational study included 123 patients with histologically confirmed pulmonary sarcoidosis and 51 controls. According to the 2024 American Heart Association diagnostic probability framework, 25 patients were classified as having highly probable or probable cardiac sarcoidosis (CS+), whereas 98 were classified as possible/low probability (CS−). All participants underwent conventional echocardiography and STE with assessment of left ventricular global longitudinal strain (LV-GLS), right ventricular global longitudinal strain (RV-GLS), right ventricular free-wall strain (RV-FWS), and LV segmental strain. Multivariable linear regression analyses were performed to assess the associations of global strain parameters with log-transformed NT-proBNP and 6-min walk distance (6MWD), adjusting for age, sex, body mass index, hypertension, and diabetes mellitus. Results: LV-GLS was progressively impaired across controls, CS−, and CS + patients (−19.02 ± 2.03%, −16.96 ± 3.32%, and −13.17 ± 4.08%, respectively; p < 0.001). RV-GLS and RV-FWS were also significantly impaired in CS + patients (p = 0.004 and p = 0.035, respectively). Segmental analysis demonstrated predominant impairment of basal and mid-ventricular segments, particularly the inferoseptal and inferior regions. NT-proBNP levels increased across the groups (49 [34–65], 100 [70–153], and 170 [114–713] pg/mL, respectively; p < 0.001). After multivariable adjustment, LV-GLS (β = 0.287, p = 0.001), RV-GLS (β = 0.231, p = 0.010), and RV-FWS (β = 0.210, p = 0.020) were independently associated with log-transformed NT-proBNP. LV-GLS was also independently associated with 6MWD (β = −0.262, p = 0.003), whereas RV-GLS and RV-FWS were not. Conclusion: Myocardial deformation is impaired in pulmonary sarcoidosis, with the greatest abnormalities observed in patients with cardiac involvement. LV-GLS showed independent associations with both NT-proBNP and functional capacity, while segmental strain analysis revealed a characteristic basal and mid-ventricular pattern of myocardial dysfunction. STE may provide useful complementary information for the assessment of myocardial involvement and clinical severity in patients with sarcoidosis.